Synthaverse S.A.

  • Our team CPHI Frankfurt 2022
About Synthaverse S.A.

We are a Polish pharmaceutical company with almost 100 years of tradition, and constantly looking for new ways of development. Many years of experience and achievements of the company are the best proof of our commitment, the beneficiaries of which are our business partners and patients themselves.
Our goal is to create an effective, modern and dynamically developing organization in the Life Science industry. We already deliver our drugs to nearly 50 countries around the world, and our ambition is to become a global leader, setting trends and benchmarks on the market.

  • PL
  • 2023
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Contact info
  • 10 Uniwersytecka Street, 20-029, Lublin, Poland

Products from Synthaverse S.A. (3)

  • Anti-tuberculosis vaccine BCG10

    Product Anti-tuberculosis vaccine BCG10

    BCG 10 Anti-Tuberculosis Vaccine is used for protective vaccinations against tuberculosis. Catch-up (supplementary) vaccinations in subjects unvaccinated after birth should be performed as early as possible, no later than at 15 years of age. In case of BCG immunisation booster vaccine doses are not recomme...
  • Distreptaza

    Product Distreptaza

    Rectal suppositories indicated for:

    1) Supportive treatment of pelvic inflammatory disease (PID) –  inflammatory diseases of the ovaries, fallopian tubes and endometrium,
    2) Adhesions after abdominal surgical procedures,
    3) Acute haemorrhoidal disease and chronic haemorr...
  • Onko BCG 100

    Product Onko BCG 100

    BCG for immunotherapy.
    The product is intended for treatment of superficial, epithelial non-invasive urothelial carcinomas (carcinoma urotheliale Ta, Tis, T1)

    1 ampoule or 1 vial with the powder contains:
    Live attenuated bacilli Bacillus Calmette-Guerin, Brazilian BCG Moreau substrain ...